Skip to main
TFX

Teleflex (TFX) Stock Forecast & Price Target

Teleflex (TFX) Analyst Ratings

Based on 9 analyst ratings
Buy
Strong Buy 11%
Buy 44%
Hold 44%
Sell 0%
Strong Sell 0%

Bulls say

Teleflex is well-positioned in the medical technology industry, with a diversified product portfolio and a strong presence in the Americas. The company has a solid track record of delivering revenue and EPS beats, and its recent strategic divestitures and cost-saving initiatives are expected to improve its financials in the near future. Furthermore, the appointment of a new CEO with a successful track record in the industry and the company's commitment to sustainability and social responsibility further support a positive outlook for the stock.

Bears say

Teleflex is expected to see a decline in its revenue growth in 2026, which may negatively impact their earnings power. Additionally, any delays or disruptions related to their planned business divestiture could hurt investor sentiment and stock performance. Furthermore, the near-term headwind caused by a third-party supplier recall could lead to elevated back orders and potentially impact full year revenue. The company's CSR framework includes pillars such as ethics and governance, planet and environment, people and human rights, and prosperity and sustainable procurement, which could potentially help their reputation and brand value.

Teleflex (TFX) has been analyzed by 9 analysts, with a consensus rating of Buy. 11% of analysts recommend a Strong Buy, 44% recommend Buy, 44% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Teleflex and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Teleflex (TFX) Forecast

Analysts have given Teleflex (TFX) a Buy based on their latest research and market trends.

According to 9 analysts, Teleflex (TFX) has a Buy consensus rating as of Aug 5, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $148, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $148, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Teleflex (TFX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.